Advisory Research’s Savara SVRA Stock Holding History

Advisory Research’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,129	Closed	-$99.3K	–	301
2023 Q4	$99.3K	Buy	+21,129	New	+$81K	0.02%	330

Other funds holding SVRA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisory Research's SVRA Position: Q1 2024 in Review

Advisory Research sold out of Savara (SVRA) in Q1 2024, closing a stake of 21,129 shares — an estimated $99.3K sold.

Advisory Research first reported a position in SVRA in Q4 2023 and held it in 1 quarter. The position peaked at $99.3K in Q4 2023. 119 funds tracked by Wall St. Rank hold SVRA as of Q1 2024.

Advisory Research reported no remaining Savara position as of Q1 2024 after selling out during the quarter.
Advisory Research sold 21,129 Savara shares in Q1 2024, an estimated $99.3K.
Advisory Research first reported a position in Savara in Q4 2023 and held it in 1 quarter.
Advisory Research's Savara position peaked at $99.3K in Q4 2023.
119 funds tracked by Wall St. Rank held Savara as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.